Skip To Main Content

독감, 백신, 에플루엘다, 에플루엘다가격, 에플루엘다효능, 독감에플루엘다, 고용량독감백신, 선택형백신, 독감백신, 예방접종, 감기에좋은음식, 기침멈추는법, 기침에좋은차, 독감이빨리낫는법, 기관지에좋은음식, 기침가래에좋은약, 감기빨리낫는법, 기침계속, 기침가래, 예방접종증명서, 기침, 기관지, 백신추천, 예방접종확인

CDC, Centers for Disease Control and Prevention; CI, confidence interval; GMT, geometric mean titer; HA, hemagglutinin; HAI, hemagglutination inhibition; HD-TIV, high-dose trivalent influenza vaccine; RCT, randomized controlled trial; rVE, relative vaccine effectiveness; SAEs, serious adverse events; SD-TIV, standard-dose trivalent influenza vaccine; VAERS, vaccine adverse event reporting system.

  1.  의약품안전나라 의약품통합정보시스템. 에플루엘다프리필드시린지. Available at https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetailCache?cacheSeq=202500885aupdateTs2025-04-23%2008:10:30.831909b. Accessed on Jul. 29, 2025. 
  2. Diaco M, et al. Vaccine. 2021;39 Suppl 1:A1-A5. 
  3. 의약품통합정보시스템. 의약품제품정보. 박씨그리프주. Available at https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetailCache?cacheSeq=202500839aupdateTs2025-06-30%2014:38:09.0b. Accessed on Jul. 30, 2025.
  4. Samson SI, et al. Expert Rev Vaccines. 2019;18:295-308. 
  5. 식품의약품안전처. 식품의약품안전 평가원. 백신 임상평가 가이드라인 (2017.6).
  6. DiazGranados CA, et al. N Engl J Med. 2014;371(7):635-645. 
  7. DiazGranados CA, et al. N Engl J Med. 2014;371(7):635-645(Protocol). 
  8. DiazGranados CA, et al. Vaccine. 2013;31(6):861-866. 
  9. Moro PL et al. Vaccine. 2020;38(37):5923-5926.
  10. Government of Canada. Influenza vaccines: Canadian Immunization Guide. Available at https://www.Canada.ca/en/public-health/services/publications/healthy-living/Canadian-immunization-guide-part-4- active-vaccines/page-10-influenza-vaccine.html#a5.2. Accessed on Apr. 07, 2025.
  11. Grohskopf LA, et al. MMWR Recomm Rep. 2024;73(5):1-25.
  12. Belgium. Conseil Superieur de la Santé- 2024-2025. Available at https://www.vivalis.brussels/sites/default/files/2024-09/Vaccination%20contre%20la%20grippe%20saisonni%C3%A8re%20-%20saison%20 hivernal%202024-2025.pdf. Accessed on Apr. 07, 2025.
  13. JCVI statement on influenza vaccines for 2025 to 2026 – GOV. Available at https://www.gov.uk/government/publications/flu-vaccines-2025-to-2026-jcvi-advice Accessed on Jul. 08, 2025.
  14. France Haute Autorité de Santé – Vaccination Available at https://www.has-sante.fr/jcms/p_3604446/fr/vaccination-contre-la-grippe-saisonniere-des-personnes-de-65-ans-et-plus-place-des-vaccins- eflueldaet-fluad Accessed on Jul. 08, 2025.
  15. ECDC. Survey report on national seasonal influenza vaccination recommendations and coverage rates in EU/EEA countries. Data from the 2024 ECDC influenza survey, 2021–22 to 2023–24 influenza seasons.
  16. Portugal: DGS. 2024. Available at https://www.portugal.gov.pt/download-ficheiros/ficheiro.aspx?v=%3d%3dBQAAAB%2bLCAAAAAAABAAzNDEyMQMATV5VdgUAAAA%3d. Accessed on Apr. 07, 2025.
  17. Switzerland. Available at https://backend.bag.admin.ch/fileservice/sdweb-docs-prod-bagadminch-files/files/2025/05/08/5f1f0792-3b3d-4aab-9ed8-35ffe6cfd44b.pdf. Accessed on Aug. 04, 2025.
  18. Italy Ministero della Salute. OGGETTO: Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2024-2025. Available at https://www.trovanorme.salute.gov.it/norme/ renderNormsanPdf?anno=2024&codLeg=100738&parte=1%20&serie=null. Accessed on Aug. 04, 2025.
  19. ROBERT KOCH INSTITUT. Epidemiologisches Bulletin 2025.4.
  20. Denmark. Health Authority. 2023. Available at https://www.sst.dk/-/media/Udgivelser/2023/Vaccination/2023-2024/Foreloebig-indstilling-til-maalgrupper-og-vaccinetyper-til-indkoeb.ashx. Accessed on Apr. 07, 2025.
  21. Latvia Veselības ministrija. Rekomendētā vakcinācija un piemērotākās vakcīnas PIEAUGUŠAJIEM. Available at https://www.vm.gov.lv/lv/imunizacijas-valsts-padome?utm_source=https%3A%2F%2Fwww.go ogle.com%2F. Accessed on Jun. 23, 2025.
  22. Czech Republic. NICO. 2022. Available at https://www.vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-3. Accessed on Apr. 07, 2025.
  23. Austria. Bundesministerium Arbeit, Soziales, Gesundheit, Pflege und Konsumentenschuts. Impfplan Österreich 2024/2025. Version 1.1 vom 18.12.2024. Available at https://www.sozialministerium.at/ Themen/Gesundheit/Impfen/Impfplan-%C3%96sterreich.html. Accessed on Apr. 07, 2025.
  24. Romania: MoH. 2023. Available at https://legislatie.just.ro/Public/DetaliiDocument/274834. Accessed on Apr. 07, 2025.
  25. Cyprus. MoH 2023 National Advisory Committee. Available at https://cyprus-mail.com/2023/09/22/simultaneous-covid-and-flu-vaccinations-to-begin-from-october/. Accessed on Apr. 07, 2025.
  26. Greece. National Adult Immunization Program 2025 Schedule and Recommendations Available at https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/ethniko- programmaemboliasmwn-epe-enhlikwn/13219-ethniko-programma-emboliasmwn-enhlikwn-2025-xronodiagramma-kai-systaseis?dl=1. Accessed on Jul. 08, 2025.
  27. Israel. MoH. 2023. Available at https://www.gov.il/BlobFolder/reports/committee-infectious-diseases-vaccines-summary-2023/he/files_committees_committee-infectious-diseases-vaccines_ CMV_08022023.pdf. Accessed on Apr. 07, 2025.
  28. United Arab Emirates: ADPHC. 2023. Available at https://www.doh.gov.ae/-/media/A350695766F547B4AAEF90C30270EDE4.ashx. Accessed on Apr. 07, 2025.
  29. ECONOMIST IMPACT. Unmasking the risk and burden of seasonal influenza in the Middle East. Available at https://www.researchgate.net/publication/392160314_Unmasking_the_risk_and_bu rden_of_seasonal_influenza_in_the_Middle_East_Strengthening_prevention_and_control_strategies_for_a_healthier_tomorrow_Unmasking_the_risk_and_burden_of_seasonal_influenza_in_t/ link/683707bc6b5a287c304716f0/download?_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6InB1YmxpY2F0aW9uIiwicGFnZSI6InB1YmxpY2F0aW9uIn19. Accessed on Aug. 04, 2025.
  30. A joint Australian, State and Territory Government Initiative. Available at https://www.health.gov.au/sites/default/files/2025-03/2025-influenza-vaccination-program-advice-for-health-professionals_0.pdf. Accessed on Apr. 07, 2025.
  31. Lee JKH, et al. Vaccine X. 2023;14:100327.

에플루엘다  프리필드시린지(인플루엔자분할백신)
제품정보는 LINK를 통해 확인하시기 바랍니다. (문안개정년월일 2025.04.14)
광고심의필 2025-1774-105802
※ 백신은 의사가 처방해야 하는 의약품으로 의사와 상의하십시오. 
※ 부작용이 있을 수 있으니 ‘사용상의 주의사항’을 잘 읽고, 의사·약사와 상의하십시오. 인터넷 의약품 판매행위는 불법입니다. 

 

주식회사 사노피-아벤티스 코리아, 서울특별시 서초구 반포대로 235 (우편번호 06578)       | 이용약관 | 법적고지 | 쿠키정책 |

대표자 : 배경은
사업자등록번호 : 220-81-00544
대표전화번호: (02)2136-9000
팩스번호: 02-2136-9588

문의사항은 잠재적인 이상사례 보고를 위해 모니터링 되고, 이상사례의 추가정보를 위해 회사로부터 연락 받으실 수 있습니다.
문의사항은 법 및 규정 준수의 의무를 위해 회사가 수집합니다.

MAT-KR-2501438-2.0-09/2025